Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Effects on Eye Movements and Self-Report Measures
NCT07604246Recruiting
- Sponsor
- The Ohio State University Comprehensive Cancer Center – James Cancer Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of nicotine inhaler, sponsored by The Ohio State University Comprehensive Cancer Center – James Cancer Hospital. Primary endpoints: Change in prosaccade latency and velocity at 30 months, Change in antisaccade error rate and latency at 30 months and 6 more. Started Aug 2026; status: recruiting.
02
Drugs
nicotine inhaler
Beyond the preview
Go deeper on NCT07604246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07604246.